Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk? CETP inhibition as a strategy to reduce cardiovascular risk: The pro case

Philip J. Barter, Stephen J. Nicholls, John J.P. Kastelein, Kerry Anne Rye

Research output: Contribution to journalArticleOtherpeer-review

23 Citations (Scopus)
Original languageEnglish
Pages (from-to)423-432
Number of pages10
Issue number5
Publication statusPublished - 4 Aug 2015
Externally publishedYes

Cite this